Get 20% off all conjugated antibody purchases with code "CON-ANTIBODY2025"! Offer valid on direct orders only. Available for US customers and internationally through distributors.

Contact us at 1.800.501.7654 or info@biossusa.com

MenuSearch

SARS-CoV-2 / COVID-19 Collection

SARS-CoV-2 / COVID-19 Collection


×

Collection Menu

Catalog #1: BSKV0001

Applications:

Reactivity: SARS-CoV-2

Conjugate:

Biotinylated Recombinant SARS-CoV-2 S protein RBD on Tris-Bis PAGE under reduced condition. The purity is great than 95%.
The purity of Biotinylated SARS-CoV-2 S protein RBD is greater than 95% as determined by SEC-HPLC.
Immobilized n-COV RBD at 1ug\/ml (100ul\/Well). Dose-response curve for Biotinylated ACE2 with the EC50 of 0.1ug\/ml determined by ELISA.

Catalog #1: bs-46003P-Biotin

Applications: WB, ELISA, HPLC, SDS-PAGE

Reactivity: SARS-CoV-2

Conjugate: Biotin

Biotinylated Recombinant SARS-CoV-2 Spike S1 protein on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
The purity of biotinylated SARS-CoV-2 Spikee S1 is greater than 95% as determined by SEC-HPLC.
Immobilized biotinylated n-COV S1, His Tag at 1ug\/ml (100ul\/Well). Dose-response curve for ACE2, Fc tag with the EC50 of 81ng\/ml determined by ELISA.

Catalog #1: bs-46004P-Biotin

Applications: WB, ELISA, HPLC

Reactivity: SARS-CoV-2

Conjugate: Biotin

Lane 1: SARS-CoV-2 N protein(Cat# bs-41408P) at 50ng; Lane 2: SARS-CoV-2 N protein(Cat# bs-41408P) at 25ng; Lane 3: SARS-CoV-2 N protein(Cat# bs-41408P) at 5ng; Lane 4: SARS-CoV-2 N protein(Cat# bs-41408P) at 2ng ; Lane 5: SARS-CoV-2 N protein(Cat# bs-41408P) at 1ng;Lane 6: SARS-CoV-2 N protein(Cat# bs-41408P) at 0.5ng probed with SARS-CoV-2 N protein monoclonal Antibody, Unconjugated (bsm-41413M) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.
Lane 1: Recombinant SARS-CoV-2 N protein (WT) (His Tag) (bs-41408P); Lane 2: Recombinant SARS-CoV-2 N protein (Q9H, P67S, P80R, P151L, S183Y) (His Tag) (bs-41451P); Lane 3: Recombinant SARS-CoV-2 N protein (D3L, P13T, D103Y, D128Y, H145Y, R203K, G204R, T205I, S235F) (His Tag) (bs-41452P); Lane 4: Recombinant SARS-CoV-2 N protein (Del204, Del215) (His Tag) (bs-41491P); Lane 5: Recombinant SARS-Cov-2 N protein (R203M, D377Y) (His Tag) (bs-41492P); Lane 6: Recombinant SARS-Cov-2 (Omicron, B.1.1.529) N protein (P13L, E31del, R32del, S33del, R203K, G204R) (N-His Tag) (bs-41494P) probed with SARS-CoV-2(2019-nCoV)Nucleocapsid Monoclonal Antibody, Unconjugated (bsm-41413M) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.

Catalog #1: bsm-41413m-100ul

Applications: WB, ELISA, FCM

Reactivity:

Conjugate: Unconjugated

Lane 1: SARS-CoV-2 N protein(Cat# bs-41408P) at 50ng; Lane 2: SARS-CoV-2 N protein(Cat# bs-41408P) at 25ng; Lane 3: SARS-CoV-2 N protein(Cat# bs-41408P) at 5ng; Lane 4: SARS-CoV-2 N protein(Cat# bs-41408P) at 2ng ; Lane 5: SARS-CoV-2 N protein(Cat# bs-41408P) at 1ng;Lane 6: SARS-CoV-2 N protein(Cat# bs-41408P) at 0.5ng probed with SARS-CoV-2 N protein monoclonal Antibody, Unconjugated (bsm-41412M) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.
Lane 1: Recombinant SARS-CoV-2 N protein (WT) (His Tag) (bs-41408P); Lane 2: Recombinant SARS-CoV-2 N protein (Q9H, P67S, P80R, P151L, S183Y) (His Tag) (bs-41451P); Lane 3: Recombinant SARS-CoV-2 N protein (D3L, P13T, D103Y, D128Y, H145Y, R203K, G204R, T205I, S235F) (His Tag) (bs-41452P); Lane 4: Recombinant SARS-CoV-2 N protein (Del204, Del215) (His Tag) (bs-41491P); Lane 5: Recombinant SARS-Cov-2 N protein (R203M, D377Y) (His Tag) (bs-41492P); Lane 6: Recombinant SARS-Cov-2 (Omicron, B.1.1.529) N protein (P13L, E31del, R32del, S33del, R203K, G204R) (N-His Tag) (bs-41494P) probed with SARS-CoV-2(2019-nCoV)Nucleocapsid Monoclonal Antibody, Unconjugated (bsm-41412M) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.

Catalog #1: bsm-41412m-100ul

Applications: WB, ELISA

Reactivity:

Conjugate: Unconjugated

Catalog #1: bsm-41415m-100ul

Applications: WB, ELISA

Reactivity:

Conjugate: Unconjugated

Lane 1: SARS-CoV-2 N protein(Cat# bs-41408P) at 50ng; Lane 2: SARS-CoV-2 N protein(Cat# bs-41408P) at 25ng; Lane 3: SARS-CoV-2 N protein(Cat# bs-41408P) at 15ng; Lane 4: SARS-CoV-2 N protein(Cat# bs-41408P) at 10ng ; Lane 5: SARS-CoV-2 N protein(Cat# bs-41408P) at 5ng;Lane 6: SARS-CoV-2 N protein(Cat# bs-41408P) at 2.5ng probed with SARS-CoV-2 N protein Polyclonal Antibody, Unconjugated (bs-41408R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.
Lane 1: SARS-CoV N protein(Cat# bs-49002P) at 50ng; Lane 2: SARS-CoV N protein(Cat# bs-49002P) at 25ng; Lane 3: SARS-CoV N protein(Cat# bs-49002P) at 15ng; Lane 4: SARS-CoV N protein(Cat# bs-49002P) at 10ng ; Lane 5: SARS-CoV N protein(Cat# bs-49002P) at 5ng;Lane 6: SARS-CoV N protein(Cat# bs-49002P) at 2.5ng\uff1bLane 7: SARS-CoV-2 N protein(Cat# bs-41408P) at 50ng; Lane 8: SARS-CoV-2 N protein(Cat# bs-41408P) at 25ng; Lane 9: SARS-CoV-2 N protein(Cat# bs-41408P) at 15ng; Lane 10: SARS-CoV-2 N protein(Cat# bs-41408P) at 10ng ; Lane 11: SARS-CoV-2 N protein(Cat# bs-41408P) at 5ng;Lane 12: SARS-CoV-2 N protein(Cat# bs-41408P) at 2.5ng probed with SARS-CoV-2 N protein Polyclonal Antibody, Unconjugated (bs-41408R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.

Catalog #1: bs-41408r-100ul

Applications: WB, ELISA

Reactivity:

Conjugate: Unconjugated

Recombinant SARS-CoV-2 protein RBD on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
The purity of SARS-CoV-2 protein RBD is greater than 95% as determined by SEC-HPLC.

Catalog #1: bs-46003P

Applications: WB, ELISA, HPLC, SDS-PAGE

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

Recombinant SARS-CoV-2 Spike S1 protein on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
The purity of SARS-CoV-2 Spikee S1 is greater than 95% as determined by SEC-HPLC.
Immobilized nCOV S1 at 0.5ug\/ml(100ul\/Well). Dose response curve for Biotinylated Human ACE2 with the EC50 of 0.2ug\/ml determined by ELISA.

Catalog #1: bs-46004P

Applications: WB, ELISA, HPLC

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

Recombinant SARS-CoV-2 Spike S1 protein on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
The purity of SARS-CoV-2 Spike S1 is greater than 95% as determined by SEC-HPLC.
Immobilized biotinylated ACE2, His Tag at 0.5ug\/ml (100ul\/Well). Dose response curve for Spike S1, Fc tag with the EC50 of 0.1ug\/ml determined by ELISA.

Catalog #1: bs-46006P

Applications: WB, ELISA, HPLC

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

Catalog #1: BSKV0004

Applications:

Reactivity: SARS-CoV-2

Conjugate:

Catalog #1: bsm-41267M

Applications: WB, ELISA

Reactivity:

Conjugate: Unconjugated

Catalog #1: BSKV0003

Applications:

Reactivity: SARS-CoV-2

Conjugate:

Recombinant SARS-CoV-2 S protein RBD on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
The purity of SARS-CoV-2 S protein RBD is greater than 95% as determined by SEC-HPLC.

Catalog #1: bs-46005P

Applications: WB, ELISA, HPLC

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

The purity of the protein is greater than 90% as determined by reducing SDS-PAGE.
Measured by its binding ability in a functional ELISA. Immobilized human ACE2, His-Avi Tag (Cat: bs-46001P) at 2\u03bcg\/ml (100ul\/Well) can bind SARS-CoV-2 Spike RBD (L452R, T478K), His Tag (Cat: bs-43048P), the EC50 is 41ng\/ml.\r\n

Catalog #1: bs-43048P

Applications: ELISA, SDS-PAGE

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

Recombinant SARS-CoV-2 Spike S Trimer Protein on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
The purity of SARS-COV-2 Spike S Trimer Protein is greater than 95% as determined by SEC-HPLC.
Immobilized SARS-COV-2 Spike S Trimer Protein, His Tag at 1ug\/ml (100ul\/Well). Dose-response curve for ACE2, Fc tag with the EC50 of 23.1ng\/ml determined by ELISA.

Catalog #1: bs-46013P

Applications: WB, ELISA, HPLC

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

Catalog #1: bsm-49132m-100ul

Applications: WB, ELISA

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

Recombinant SARS-CoV-2 Spike S1 (N501Y, K417YN, E484K) on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
The purity of SARS-COV-2 Spike S1 is greater than 95% as determined by SEC-HPLC.

Catalog #1: bs-46017P

Applications: WB, ELISA, HPLC

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

Catalog #1: BSKV0005

Applications:

Reactivity: SARS-CoV-2

Conjugate:

Catalog #1: bsm-41268M

Applications: WB, ELISA

Reactivity:

Conjugate: Unconjugated

Catalog #1: bsm-41267M-HRP

Applications: WB, ELISA

Reactivity:

Conjugate: HRP

The purity of the protein is greater than 90% as determined by reducing SDS-PAGE.
Measured by its binding ability in a functional ELISA. Immobilized human ACE2, His-Avi Tag (Cat: bs-46001P) at 2\u03bcg\/ml (100ul\/Well) can bind SARS-CoV-2 Spike RBD (N501Y), His Tag (Cat: bs-41448P), the EC50 is 8.34ng\/ml.\r\n

Catalog #1: bs-41448P

Applications: ELISA, SDS-PAGE

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

Recombinant SARS-CoV-2 Spike RBD (N501Y, K417N, E484K) on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
The purity of SARS-CoV-2 Spike RBD is greater than 95% as determined by SEC-HPLC.
Immobilized SARS-CoV-2 Spike RBD (N501Y, K417N, E484K), at 0.5ug\/ml (100ul\/Well). Dose-response curve for ACE2, hFc tag with the EC50 of 0.48ug\/ml determined by ELISA.

Catalog #1: bs-46018P

Applications: WB, ELISA, HPLC

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

SARS-COV-2 S protein RBD (N501Y) on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.\r\n
The purity of SARS-COV-2 S protein RBD (N501Y) is greater than 95% as determined by SEC-HPLC.
Human ACE2 captured on protein A chip, can bind SARS-CoV S protein RBD (N501Y), His tag with an affinity constant of 1.7nM as determined in SPR assay (Biacore T200).
Immobilized SARS-CoV-2 S RBD (N501Y) protein, His Tag at 0.5ug\/ml (100ul\/Well). Dose-response curve for ACE2, Fc tag with the EC50 of 12.7ng\/ml determined by ELISA.

Catalog #1: bs-46011P

Applications: WB, ELISA, HPLC

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

Catalog #1: bsm-41268M-Biotin

Applications: WB, ELISA

Reactivity:

Conjugate: Biotin

Catalog #1: bsm-41267M-Biotin

Applications: WB, ELISA

Reactivity:

Conjugate: Biotin

Catalog #1: bsm-70256M

Applications: WB, ICC

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

Catalog #1: bsm-70255M

Applications: WB, ICC

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

Catalog #1: bs-70257r-100ul

Applications: WB

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

Catalog #1: bsm-41511R-HRP

Applications: ELISA

Reactivity: SARS-CoV-2, SARS-CoV-2 Omicron

Conjugate: HRP

Catalog #1: bsm-41511R-Biotin

Applications: ELISA

Reactivity: SARS-CoV-2, SARS-CoV-2 Omicron

Conjugate: Biotin

Lane 1: SARS-CoV-2 N protein(WT) at 10ng; Lane 2: SARS-CoV-2 N protein(Q9H, P67S, P80R, P151L, S183Y) at 2ng; Lane 3: SARS-CoV-2 N protein (D3L, P13T, D103Y, D128Y,H145Y, R203K, G204R, T205I, S235F) at 2ng; Lane 4: SARS-CoV-2 N protein (Del204 & Del215) at 2ng; Lane 5: SARS-CoV-2 N protein (R203M & D377Y) at 2ng probed with anti-SARS-CoV-2 N protein monoclonal antibody, Unconjugated (bsm-41511R) at 1:1000 dilution and 4\u2103 overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60min at 37 \u2103
Measured by its binding ability in a functional ELISA. Immobilized SARS-CoV-2 NP (bs-41417P) at 2\u03bcg\/mL (100\u03bcL\/well) can bind anti-SARS-CoV-2 NP monoclonal antibody, the EC50 for this effect is 7.8-15ng\/ml.

Catalog #1: bsm-41511R

Applications: ELISA, LFA

Reactivity: SARS-CoV-2, SARS-CoV-2 Omicron

Conjugate: Unconjugated

Catalog #1: bsm-41481M-HRP

Applications: ELISA

Reactivity: SARS-CoV-2, SARS-CoV-2 Omicron

Conjugate: HRP

Catalog #1: bsm-41481M-Biotin

Applications: ELISA

Reactivity: SARS-CoV-2, SARS-CoV-2 Omicron

Conjugate: Biotin

Lane 1: SARS-CoV-2 N protein(WT) at 10ng; Lane 2: SARS-CoV-2 N protein(Q9H, P67S, P80R, P151L, S183Y) at 2ng; Lane 3: SARS-CoV-2 N protein (D3L, P13T, D103Y, D128Y,H145Y, R203K, G204R, T205I, S235F) at 2ng; Lane 4: SARS-CoV-2 N protein (Del204 & Del215) at 2ng; Lane 5: SARS-CoV-2 N protein (R203M & D377Y) at 2ng probed with anti-SARS-CoV-2 N protein monoclonal antibody, Unconjugated (bsm-41481M) at 1:1000 dilution and 4\u2103 overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60min at 37 \u2103.
Measured by its binding ability in a functional ELISA. Immobilized SARS-CoV-2 NP (bs-41417P) at 2\u03bcg\/mL (100\u03bcL\/well) can bind anti-SARS-CoV-2 NP monoclonal antibody, the EC50 for this effect is 3.6-7.8ng\/ml.

Catalog #1: bsm-41481M

Applications: ELISA, LFA

Reactivity: SARS-CoV-2, SARS-CoV-2 Omicron

Conjugate: Unconjugated

Catalog #1: bsm-41518M-PE-Cy5.5

Applications: WB

Reactivity: SARS-CoV-2

Conjugate: PE-Cy5.5

Catalog #1: bsm-41518M-RBITC

Applications: WB

Reactivity: SARS-CoV-2

Conjugate: RBITC

Catalog #1: bsm-41518M-PerCP-Cy5.5

Applications: WB

Reactivity: SARS-CoV-2

Conjugate: PerCP-Cy5.5

Catalog #1: bsm-41518M-PerCP

Applications: WB

Reactivity: SARS-CoV-2

Conjugate: PerCP

Catalog #1: bsm-41518M-PE-Cy7

Applications: WB

Reactivity: SARS-CoV-2

Conjugate: PE-Cy7

Catalog #1: bsm-41518M-PE-Cy5

Applications: WB

Reactivity: SARS-CoV-2

Conjugate: PE-Cy5

Catalog #1: bsm-41518M-APC-Cy5.5

Applications: WB

Reactivity: SARS-CoV-2

Conjugate: APC-Cy5.5

Catalog #1: bsm-41518M-APC-Cy7

Applications: WB

Reactivity: SARS-CoV-2

Conjugate: APC-Cy7

Catalog #1: bsm-41518M-APC

Applications: WB

Reactivity: SARS-CoV-2

Conjugate: APC

Catalog #1: bsm-41518M-BF750

Applications: WB

Reactivity: SARS-CoV-2

Conjugate: AbBy Fluor® 750

Catalog #1: bsm-41518M-BF680

Applications: WB

Reactivity: SARS-CoV-2

Conjugate: AbBy Fluor® 680

Catalog #1: bsm-41518M-BF647

Applications: WB

Reactivity: SARS-CoV-2

Conjugate: AbBy Fluor® 647

Catalog #1: bsm-41518M-BF555

Applications: WB

Reactivity: SARS-CoV-2

Conjugate: AbBy Fluor® 555